Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study

BACKGROUND: The use of cytokine-blocking agents has been proposed to modulate the inflammatory response in patients with COVID-19. Tocilizumab and anakinra were included in the local protocol as an optional treatment in critically ill patients with acute respiratory distress syndrome (ARDS) by SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Coloretti, Irene, Busani, Stefano, Biagioni, Emanuela, Venturelli, Sophie, Munari, Elena, Sita, Marco, DallAra, Lorenzo, Tosi, Martina, Clini, Enrico, Tonelli, Roberto, Fantini, Riccardo, Mussini, Cristina, Meschiari, Marianna, Guaraldi, Giovanni, Cossarizza, Andrea, Alfano, Gaetano, Girardis, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139121/
https://www.ncbi.nlm.nih.gov/pubmed/34040779
http://dx.doi.org/10.4081/mrm.2021.737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139121/
https://www.ncbi.nlm.nih.gov/pubmed/34040779
http://dx.doi.org/10.4081/mrm.2021.737

Ejemplares similares